Follow
Alar Aints
Alar Aints
Associate professor, Department of Immunology, University of Tartu
Verified email at ut.ee
Title
Cited by
Cited by
Year
Bruton’s tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain
AJ Mohamed, L Yu, CM Bäckesjö, L Vargas, R Faryal, A Aints, ...
Immunological reviews 228 (1), 58-73, 2009
6302009
Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22
MS Dilber, A Phelan, A Aints, AJ Mohamed, G Elliott, CI Smith, P O’hare
Gene Therapy 6 (1), 12-21, 1999
2171999
Gap junction-mediated bystander effect in primary cultures of human malignant gliomas with recombinant expression of the HSVtk gene
T Asklund, IB Appelskog, O Ammerpohl, IA Langmoen, MS Dilber, A Aints, ...
Experimental cell research 284 (2), 183-193, 2003
1312003
Anti-myeloma activity of endogenous and adoptively transferred activated natural killer cells in experimental multiple myeloma model
E Alici, KV Konstantinidis, T Sutlu, A Aints, G Gahrton, HG Ljunggren, ...
Experimental hematology 35 (12), 1839-1846, 2007
742007
Efficient gene transfer into primary human natural killer cells by retroviral transduction
H Guven, KV Konstantinidis, E Alici, A Aints, M Abedi-Valugerdi, ...
Experimental hematology 33 (11), 1320-1328, 2005
662005
Intercellular spread of GFP‐VP22
A Aints, MS Dilber, CIE Smith
The journal of gene medicine 1 (4), 275-279, 1999
621999
Targeting IL-2 to the endoplasmic reticulum confines autocrine growth stimulation to NK-92 cells
KV Konstantinidis, E Alici, A Aints, B Christensson, HG Ljunggren, ...
Experimental hematology 33 (2), 159-164, 2005
572005
Mapping of herpes simplex virus-1 VP22 functional domains for inter-and subcellular protein targeting
A Aints, H Güven, G Gahrton, CIE Smith, MS Dilber
Gene therapy 8 (14), 1051-1056, 2001
542001
Visualization of 5T33 myeloma cells in the C57BL/KaLwRij mouse: establishment of a new syngeneic murine model of multiple myeloma
E Alici, KV Konstantinidis, A Aints, MS Dilber, M Abedi-Valugerdi
Experimental hematology 32 (11), 1064-1072, 2004
462004
Lentiviral-mediated HoxB4 expression in human embryonic stem cells initiates early hematopoiesis in a dose-dependent manner but does not promote myeloid differentiation
C Unger, E Kärner, A Treschow, B Stellan, U Felldin, H Concha, ...
Stem Cells 26 (10), 2455-2466, 2008
452008
Culture and expansion of the human embryonic stem cell line HS181, evaluated in a double-color system
MP Imreh, S Wolbank, C Unger, K Gertow, A Aints, A Szeles, S Imreh, ...
Stem Cells and Development 13 (4), 337-343, 2004
352004
OuaSelect, a novel ouabain-resistant human marker gene that allows efficient cell selection within 48 h
A Treschow, C Unger, A Aints, U Felldin, J Aschan, MS Dilber
Gene therapy 14 (22), 1564-1572, 2007
192007
Thinning and drilling laser-assisted hatching in thawed embryo transfer: A randomized controlled trial
MT Le, TTA Nguyen, TTT Nguyen, DD Le, VQH Nguyen, NT Cao, A Aints, ...
Clinical and experimental reproductive medicine 45 (3), 129, 2018
182018
Long-term follow-up of gene-marked CD34+ cells after autologous stem cell transplantation for multiple myeloma
E Alici, B Björkstrand, A Treschow, A Aints, CIE Smith, G Gahrton, ...
Cancer Gene Therapy 14 (3), 227-232, 2007
182007
PTPN22 gene regulates natural killer cell proliferation during in vitro expansion
K Douroudis, A Shcherbakova, H Everaus, A Aints
Tissue antigens 76 (4), 315-318, 2010
162010
Enhanced ouabain resistance gene as a eukaryotic selection marker
A Aints, R Belusa, RM Andersson, H Güven, MS Dilber
Human gene therapy 13 (8), 969-977, 2002
122002
OMICs studies and endometriosis biomarker identification
M Saare, M Peters, A Aints, T Laisk-Podar, A Salumets, S Altmäe
Biomarkers for Endometriosis: State of the Art, 227-258, 2017
82017
A mathematical model of natural killer cell activity
A Scherbakova, H Lust, H Everaus, A Aints
Cytometry Part A 83 (6), 585-591, 2013
62013
Proximal promoter of the murine syndecan‐1 gene is not sufficient for the developmental pattern of syndecan expression in B lineage cells
CP Volpe, A Lundgren, A Aints, AJ Mohamed, P Jaakkola, B Christensson, ...
American journal of hematology 67 (1), 20-26, 2001
52001
Method for the genetic activation of cells and uses of said cells
S Dilber, A Aints, K Konstantinidis
US Patent App. 11/171,397, 2006
42006
The system can't perform the operation now. Try again later.
Articles 1–20